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Background: Maternal glucose and lipid levels are associated with neonatal anthropometry of the offspring, also
independently of maternal body mass index (BMI). Gestational weight gain, however, is often not accounted for.
The objective was to explore whether the effects of maternal glucose and lipid levels on offspring’s birth weight
and subcutaneous fat were independent of early pregnancy BMI and mid-gestational weight gain.
Methods: In a population-based, multi-ethnic, prospective cohort of 699 women and their offspring, maternal
anthropometrics were collected in gestational week 15 and 28. Maternal fasting plasma lipids, fasting and 2-hour
glucose post 75 g glucose load, were collected in gestational week 28. Maternal risk factors were standardized using
z-scores. Outcomes were neonatal birth weight and sum of skinfolds in four different regions.
Results: Mean (standard deviation) birth weight was 3491 ± 498 g and mean sum of skinfolds was 18.2 ± 3.9
mm. Maternal fasting glucose and HDL-cholesterol were predictors of birth weight, and fasting and 2-hour glucose
were predictors of neonatal sum of skinfolds, independently of weight gain as well as early pregnancy BMI, gestational
week at inclusion, maternal age, parity, smoking status, ethnic origin, gestational age and offspring’s sex. However,
weight gain was the strongest independent predictor of both birth weight and neonatal sum of skinfolds, with a 0.21
kg/week increased weight gain giving a 110.7 (95% confidence interval 76.6-144.9) g heavier neonate, and with 0.72
(0.38-1.06) mm larger sum of skinfolds. The effect size of mother’s early pregnancy BMI on birth weight was higher in
non-Europeans than in Europeans.
Conclusions: Maternal fasting glucose and HDL-cholesterol were predictors of offspring’s birth weight, and fasting and
2-hour glucose were predictors of neonatal sum of skinfolds, independently of weight gain. Mid-gestational weight
gain was a stronger predictor of both birth weight and neonatal sum of skinfolds than early pregnancy BMI, maternal
glucose and lipid levels.
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Delivery of macrosomic babies is associated with pregnancy
complications such as shoulder dystocia in the offspring [1],
cesarean delivery and injuries to the birth canal [2]. Both
high and low birth weights have been associated with ad-
verse health outcomes for the child in later life, such as
obesity [3] and type 2 diabetes [4]. Although easy to meas-
ure, birth weight is generally considered a rough indicator of
fetal growth, as the differences in birth weight may be attrib-
uted both to differences in fat and lean mass [5]. Fat mass is
considered a sensitive marker of the fetal environment and
high amounts of fat in the newborn may predispose to obes-
ity and its metabolic complications in later life [6].
In the Hyperglycemia and Adverse Pregnancy Outcome
(HAPO) study, a continuous relationship between mater-
nal glucose levels and birth weight was demonstrated,
indicating that even moderately elevated glucose levels
may increase risk of fetal overgrowth [7]. Pedersen [8]
suggested already in 1952 that maternal hyperglycemia
transmits to the fetus and induce fetal hyperinsuline-
mia that stimulates growth and leads to increased birth
weight and excessive body fat in the offspring [8]. In
concordance with the Pedersen hypothesis, maternal
glucose is associated with birth weight [9-11]. Also,
studies have found associations between maternal lipids and
fetal growth, especially triglycerides and HDL-cholesterol,
and one study recently found total cholesterol to be of simi-
lar importance as maternal glucose for birth weight [12].
However, high maternal prepregnancy weight and gesta-
tional weight gain may result in higher risk of increased
birth weight and adverse outcomes than gestational diabetes
per se [10,13,14]. Prepregnant BMI is readily accounted for
in studies of associations between maternal glucose
and offspring’s birth weight. Gestational weight gain,
however, is often not accounted for [10], although ex-
cessive gestational weight gain has been associated with
both gestational diabetes [15,16] and infants born large for
gestational age [10,14].
The HAPO study found an association between mater-
nal glucose and neonatal fat mass [7]. However, whether
the association between maternal glucose and neonatal
fat mass is independent of weight gain in pregnancy, has
to our knowledge not been explored. Maternal glucose
and lipid levels and their associations with neonatal an-
thropometrics could therefore be influenced by maternal
weight gain in pregnancy.
The objective was to explore whether the effects of
maternal glucose and lipid levels on offspring’s birth
weight and subcutaneous fat were independent of early
pregnancy BMI and mid-gestational weight gain.
Methods
The details of the STORK Groruddalen study have been
described previously [17]. In short, it is a population-basedcohort study of healthy pregnant women attending Child
Health Clinics for antenatal care in three administrative
city districts in Oslo, Norway, May 2008-May 2010. Women
were eligible if they: 1) lived in the study districts; 2) planned
to give birth at one of two study hospitals; 3) were < 20
weeks pregnant; 4) could communicate in Norwegian or
any of the eight translated languages; and 5) were able to
give a written consent to participate. To allow for as
complete sampling as possible, a minor number of women
were included later than 20 weeks: 77 (9.4%) women were
included from gestational week 20 to 24, while 11 (1.3%)
women were included after gestational week 24. Women
with pregestational diabetes or in need of intensive hospital
follow-up during pregnancy were excluded. The women
were included in gestational week 15 (Visit 1). Measure-
ments were repeated in gestational week 28 (Visit 2), when
also an oral glucose tolerance test was performed.
The study was approved by the Norwegian “Regional
Committee for Medical and Health Research Ethics South
East” and “The Norwegian Data Inspectorate”, and a
written consent was obtained for all participants.
Questionnaire data
Maternal age, parity, smoking status and ethnic origin
were collected through interviewer-administered ques-
tionnaires at Visit 1. Maternal age was calculated based
on date of birth. Parity was dichotomized into nullipar-
ous and parous. Smoking status was collected through
two questions: 1) smoker for the last three months prior
to pregnancy and 2) smoker during pregnancy. As only
28 women smoked occasionally or daily during preg-
nancy, we collapsed the two questions before entering it
as a dummy variable into the regression analysis. Ethnic
origin was defined as country of birth or participant’s
mother’s country of birth if the participant’s mother was
born outside of Europe or North America, and divided
into Europe, South Asia, Middle East, East Asia and South
or Central Africa. Three women originating from North
America were placed in the Europe category.
Maternal early pregnancy BMI and mid-gestational weight
gain
Height was measured to the nearest 0.1 cm with a fixed
stadiometer at Visit 1. Body weight was measured with
a calibrated digital scale (Tanita-BC 418 MA, Tanita
Corporation, Tokyo, Japan) at Visit 1 and Visit 2. BMI
in early pregnancy was calculated from weight and
height measured at Visit 1. Pre-pregnancy BMI was
calculated from self-reported body weight reported at
Visit 1 and height measured at Visit 1. Mid-gestational
weight gain was defined as the difference in body
weight between Visit 1 and Visit 2, divided by the
number of weeks between the two visits for each
individual.
Figure 1 Hypothesized timeline of the multiple regression
analysis. Solid lines indicate already established relationships and
dotted lines the hypothesized relationships. We hypothesized that
maternal early pregnancy BMI and mid-gestational weight gain
could modify the effects of maternal glucose and lipids on offspring’s
birth weight and neonatal subcutaneous fat.
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Maternal glucose and lipid levels were measured at Visit
2. Fasting and 2-hour glucose post 75 g glucose load,
and fasting total-, HDL- and LDL-cholesterol and tri-
glycerides were measured from venous blood with a
colorimetric method (Vitros 5.1 FS, Ortho clinical
diagnostics) at the central laboratory. A minority of
participants (4.4% for fasting glucose, 7.2% for 2-hour
glucose) lacked valid glucose values from the central
laboratory. We supplemented missing values with values
obtained with a point of care testing device calibrated for
plasma (HemoCue 201+, Angelholm, Sweden) (for fasting
glucose: n = 20, 2.9%; for 2-hour glucose: n = 38, 5.5%), or
if point of care values were missing as well, we used values
collected from medical records (for fasting glucose n = 11,
1.6%; for 2-hour glucose n = 12, 1.7%). Women diag-
nosed with gestational diabetes by the World Health
Organization (WHO) 1999 criteria (fasting plasma glu-
cose ≥ 7.0 mmol/L or 2-hour glucose ≥ 7.8 mmol/L) at
Visit 2 received lifestyle advice and were referred to
their General Practitioner for follow-up if 2-hour glu-
cose was <9.0 mmol/L or to hospital care if 2-hour
glucose was ≥ 9.0 mmol/L [18].
Neonatal variables
To be able to compare our results with similar studies,
gestational week was calculated from the first day of the
woman’s last menstrual period (LMP) and term was cal-
culated as date of LMP +282 days (standard in Norway).
Ultrasound term (from routine scan) was used for 24
(3.4%) women where the LMP date was missing or dif-
fered ≥ 14 days from ultrasound term [19]. The outcome
birth weight was measured with calibrated electronic
scales immediately after birth [17]. To assess neonatal
subcutaneous fat, we measured skinfolds to the nearest
0.2 mm, with a skinfold caliper (Holtain T/W Skinfold
Caliper, Holtain Ltd., Crymych, UK) at subscapular, suprai-
liac, thigh and triceps sites within 72 hours after birth. We
measured all skinfolds twice and used the average. The
outcome sum of skinfolds, was calculated by summarizing
the four skinfold sites. Inter-rater variability (measured
as % Technical Error of Measurement) for the skinfold
measurements ranged from 8-13%, while intra-rater
variability was less than 5% in all measurements [19].
Statistical analysis
We used maternal early pregnancy BMI from Visit 1,
maternal weight gain from Visit 1 to Visit 2, and mater-
nal glucose and lipid level measured at Visit 2 to meet
with assumptions of temporality (Figure 1). All maternal
risk factor variables were standardized using z-score to
ease comparison of their effects on the outcomes. We
performed simple univariate linear regression analyses
(Model 0) to explore associations between maternal riskfactor variables and the outcomes birth weight and sum
of skinfolds. We performed multiple linear regressions
separately for the outcomes birth weight and sum of
skinfolds to explore independent effects of maternal risk
factor variables. In Model 1, maternal glucose and lipid
variables that correlated with the respective outcomes
with a P-value < 0.2 in Model 0, were entered simultan-
eously into a multiple regression and adjusted for gesta-
tional week at inclusion, maternal age, parity, smoking
status, ethnic origin gestational age and offspring’s sex.
To see if BMI or weight gain influenced the effect of ma-
ternal glucose and lipid levels on the outcomes, we add-
itionally adjusted for early pregnancy BMI in Model 2,
and additionally for mid-gestational weight gain in
Model 3. We explored possible interactions between the
maternal risk factor variables and ethnic origin, and be-
tween the maternal risk factor variables and offspring’s
sex, by including interaction terms into the multiple re-
gressions for both outcomes. We performed sensitivity
analyses by repeating the multiple regression analysis
after excluding 83 women who were diagnosed with ges-
tational diabetes; by using pre-pregnancy (self-reported)
weight gain to gestational week 28 and; by analyzing
normal weight and overweight women separately, ac-
cording to classifications by the WHO. All statistical
analyses were performed using IBM SPSS Statistics 21.
We used the lincom command in StataIC 12 to calculate
predicted birth weight and sum of skinfolds for the sole
and combined effects of significant risk factor variables,
based on Model 3 of the multiple regression analysis
separately for each outcome. To estimate an “optimal”
birth weight and sum of skinfolds in the offspring, we
defined an optimal early pregnancy BMI as 23 kg/m2
and an optimal weight gain was defined as 0.42 kg/week
in accordance with recommendations from the Institute
of Medicine [20]. To estimate high or low maternal glu-
cose and lipid levels we used cut offs at the 90th or the
10th percentile.
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The participation rate was 74%, varying from 63.9 to
82.6 across ethnic groups [17]. Age did not differ be-
tween the 823 who participated and the 291 who chose
not to participate. South Asians who did not participate
were more parous than those who participated, while
there was no difference within the remaining ethnic
groups [17]. The study cohort was representative for the
main ethnic groups, and there were no ethnic differences
in reasons for exclusion [17,21].
Of the 823 women originally included in the study, 751
mothers of singleton neonates met at Visit 2 (Figure 2). We
excluded 37 women with preterm births (gestational
week < 37), six who were included after gestational week 24
and nine with a South American origin due to heterogen-
eity, leaving us with a sample of 699 women and their off-
spring. We found no difference between the 124 excluded
women and the 699 included women in age, parity, educa-
tion level or duration of residence in Norway for immi-
grants. A higher proportion of the excluded women were
single (8.9% vs 3.0%, p = 0.037) and originated from South
or Central Africa (14.5% vs 6.3%, p = <0.001). Neonatal
skinfold measurements were missing for 187 offspring
mainly due to study staff not being notified of the birth
within 72 hours [19]. With sum of skinfolds as the outcome,
our sample therefore comprised 512 women and their off-
spring (Figure 2). We did not find any differences in the
characteristics listed in Table 1 between mother-offspring
pairs with and without neonatal skinfold measurements.Results
The mean maternal age was 29.3 ± 4.9 years, 45.6% (n = 319)
were nulliparous and 47.9% (n = 335) had a European ethnicFigure 2 Flow of the cohort.origin (Table 1). Mean self-reported prepregnancy BMI was
24.6 ± 4.8 kg/m2, early pregnancy BMI at Visit 1 was 25.3 ±
4.8 and mean mid-gestational weight gain between Visit 1
and Visit 2 was 0.51 ± 0.21 kg/week (Table 1). The women
were included in gestational week 15 ± 3, while maternal glu-
cose and lipids were measured in gestational week 29 ± 1.
The mean gestational age of the neonates was 281 ± 9 days,
birth weight was 3491 ± 498 g and mean sum of skinfolds
was 18.2 ± 3.9 mm (Table 1). Girls had lower birth weight
(3420 ± 491 vs. 3559 ± 491 g) and had a larger sum of skin-
fold than boys (18.6 ± 4.0 mm vs. 17.8 ± 3.8 mm).Predictors of offspring’s birth weight and sum of
skinfolds
In univariate simple regression analyses (Table 2, Model 1),
maternal fasting glucose, early pregnancy BMI, and mid-
gestational weight gain were all associated to offspring’s
birth weight (all P < 0.001), while the associations with
HDL-cholesterol (P = 0.023), 2-h glucose (P = 0.069) and
triglyceride level (P = 0.105) were non-significant. With
sum of skinfolds as the outcome, both fasting and 2-h glu-
cose (both P < 0.001), early pregnancy BMI (P < 0.001) and
mid-gestational weight gain (P = 0.006) were associated,
while the effect sizes of triglycerides (P = 0.025) and HDL-
cholesterol (P = 0.199) on sum of skinfolds were weaker.
In the multiple regression analyses adjusted for rele-
vant covariates (Table 2, Model 1) fasting glucose was a
significant predictor of birth weight and both fasting and
2-h glucose were significant predictors of sum of skin-
folds. Early pregnancy BMI was a significant and inde-
pendent predictor of offspring’s birth weight, but not for
sum of skinfolds (Table 2, Model 2). After adjusting for
early pregnancy BMI (Table 2, Model 2) the effect of








South Asia 173 (24.7)
Middle East 112 (16.0)
East Asia 35 (5.0)
South or Central Africa 44 (6.3)
Prepregnancy BMI (kg/m2) 24.6 ± 4.8
Early pregnancy BMI, Visit 1 (kg/m 2) 25.3 ± 4.8
Weight gain, Visit 1-2 (kg/week) 0.51 ± 0.21
Visit 1 (gestational week) 15 ± 3
Visit 2 (gestational week) 29 ± 1
Smoked 3 months prior to pregnancy 123 (17.6)
Smoked during pregnancy 28 (4.0)
Neonatal characteristics
Gestational age at birth (days) 281 ± 9
Female sex 337 (49.7)
Birth weight (g) 3491 ± 498
Neonatal sum of skinfolds (mm) a 18.2 ± 3.9
Mean skinfold triceps (mm) a 4.4 ± 1.0
Mean skinfold thigh (mm) a 5.9 ± 1.4
Mean skinfold suprailiac crest (mm) a 3.5 ± 0.9
Mean skinfold subscapular (mm) a 4.4 ± 1.1
Maternal glucose and lipids
Glucose
Fasting glucose (mmol/L)
Visit 1 4.4 ± 0.4
Visit 2 4.4 ± 0.5
2-hour glucose (mmol/L)
Visit 2 5.8 ± 1.5
Gestational diabetes 84 (12.2)
Lipids
Total cholesterol (mmol/L)
Visit 1 5.0 ± 0.9
Visit 2 6.2 ± 1.1
HDL-cholesterol (mmol/L)
Visit 1 1.73 ± 0.39
Visit 2 1.93 ± 0.45
LDL-cholesterol (mmol/L)
Visit 1 2.71 ± 0.73
Visit 2 3.44 ± 0.99
Table 1 Characteristics of the sample (Continued)
Triglycerides (mmol/L)
Visit 1 1.31 ± 0.55
Visit 2 1.98 ± 0.69
Data are mean ± standard deviation or n (%).
a n = 512.
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fects of fasting and 2-hour glucose on sum of skinfolds
were unchanged. Mid-gestational weight gain was a sig-
nificant and independent predictor of both offspring’s
birth weight and sum of skinfolds (Table 2, Model 3).
After adjusting for weight gain, the effect of fasting glu-
cose on both birth weight and sum of skinfolds de-
creased, but remained an independent predictor of both
outcomes, while the effect of 2-hour glucose on sum of
skinfolds was slightly increased and thereby remained an
independent predictor (Table 2). HDL-cholesterol was
not an independent predictor of birth weight until
weight gain was adjusted for, while 2-hour glucose and
triglycerides were not independently associated with birth
weight (Table 2). None of the lipid parameters were inde-
pendent predictors of sum of skinfolds (Table 2).
As women who were diagnosed with gestational dia-
betes received lifestyle advice at time of diagnose, we re-
peated the analysis without these 83 women. The effects
of the risk factor variables were unchanged except for
the effect of triglycerides on neonatal sum of skinfolds,
where the effect size increased and the association be-
came significant (β =0.45 (95% confidence interval
0.04-0.85). Using weight gain from pre-pregnancy (self-
reported) to gestational week 28 did not change the effect
estimates of the independent predictors for neither out-
come (data not shown). Analyzing normal weight and
overweight women separately, using model 3 of the re-
gression, did not change the effect estimates of the inde-
pendent predictors for neither outcome (data not shown).
Impact of ethnic origin
Compared to offspring of European mothers, the mean
birth weight was 325 (408-243) g lower in offspring of
South Asian mothers, 168 (263-73) g lower in offspring
of Middle Eastern mothers, 239 (389-89) g lower in off-
spring of East Asian mothers and 161 (303-19) g lower
in offspring of African mothers. The mean sum of
skinfolds was significantly lower by 1.7 (2.5-0.9) mm in
offspring of South Asian mothers and by 1.2 (2.2-0.2)
mm in offspring of Middle Eastern mothers than in
offspring of European mothers.
We found no interactions between ethnic origin and the
risk factor variables with sum of skinfolds as the outcome.
With birth weight as the outcome, there was a significant
interaction between ethnic origin and maternal early
Table 2 Univariate simple and multiple linear regressions of maternal risk factor variables (z-score) on offspring’s birth
weight (g) and sum of skinfolds (mm)
Model 0 Model 1 Model 2 Model 3 Model 4
Simple Adjusted Model 1 + BMI Model 2 +Weight gain Model 3 + interaction term
β P β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Birth weight (g)
Fasting glucose 83.5 <0.001 79,5 (42.5 to 115.1) 64,9 (26.5 to 103.3) 43,2 (5.4 to 81.1) 43,7 (5.9 to 81.5)
2-hour glucose 34.7 0.069 11,4 (-24.7 to 47.5) 9,7 (-26.2 to 45.7) 15,9 (-19.1 to 50.8) 16,6 (-18.3 to 51.5)
HDL-cholesterol −43.3 0.023 −28,1 (-63.1 to 6.9) −27,2 (-62.0 to 7.6) −41,6 (-75.6 to -7.5) −44,5 (-78.6 to -10.4)
Triglycerides 30,8 0.105 32,5 (-4.2 to 69.2) 27,8 (-8.7 to 64.5) 35,0 (-0.7 to 70.6) 34,9 (-0.6 to 70.5)
BMI in early pregnancy 127.2 <0.001 49,5 (12.6 to 86.4) 68,3 (32.0 to 104.5)
BMI in Europeans 33,5 (17.1 to 50.0)
BMI in non-Europeans 103,7 (54.7 to 152.7)
Weight gain a 79.5 <0.001 110,7 (76.6 to 144.9) 111,3 (77.2 to 145.3)
Sum of skinfolds (mm)
Fasting glucose 0.92 <0.001 0,75 (0.39 to 1.12 0,73 (0.36 to 1.11) 0,57 (0.19 to 0.95) 0,58 (0.20 to 0.96)
2-hour glucose 0.73 <0.001 0,40 (0.05 to 0.75) 0,40 (0.05 to 0.75) 0,44 (0.09 to 0.78) 0,44 (0.09 to 0.78)
HDL-cholesterol −0,22 0.199 −0,09 (-0.43 to 0.25) −0,09 (-0.43 to 0.26) −0,18 (-0.52 to 0.16) −0,19 (-0.54 to 0.15)
Triglycerides 0.39 0.025 0,21 (-0.15 to 0.57) 0,20 (-0.15 to 0.56) 0,24 (-0.11 to 0.60) 0,25 (-0.11 to 0.60)
BMI in early pregnancy 0.77 <0.001 0,08 (-0.30 to 0.47) 0,25 (-0.13 to 0.64)
BMI in Europeans 0,10 (-0.08 to 0.28)
BMI in non-Europeans 0,41 (-0.11 to 0.92)
Weight gain a 0.48 0.006 0,72 (0.38 to 1.06) (0.38 to 1.06)
Maternal risk factor variables are expressed as standard deviations (SDs). Values are β and P-value in Model 0, and in the remaining models; β (95% CI), with 1SD
increase in maternal risk factor variables representing a unit change in birth weight (g) or sum of skinfolds (mm).
Model 0 are simple regression analyses, listed variables analyzed separately.
Model 1 is a multiple regression of the risk factor variables entered simultaneously, adjusted for gestational week at inclusion, maternal age, parity, smoking
status, ethnic origin, offspring’s sex and gestational age.
Model 2 =model 1+ early pregnancy BMI.
Model 3 =model 2 + weight gain.
Model 4 =model 3 + interaction term, BMI X European ethnic origin. β’s for BMI are presented separately for Europeans and non-Europeans in Model 4.
Bold β value indicates P < 0.05.
a Weight gain from Visit 1 (gestational week 15) to Visit 2 (gestational week 28).
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a 4.8 kg/m2 higher BMI resulted in a 33.5 (17.1-50.0) g
heavier offspring, while for non-Europeans it resulted
in a 103.7 (54.7-152.7) g heavier offspring (Table 2,
Model 4). The effect size of BMI on birth weight was
higher in all ethnic minority sub-groups (data not
shown). Adding the interaction term to the final model
of the multiple regression analysis did not substantially
change the effect estimates for the other risk factor
variables (Table 2, Model 4).
Combined effects
Mid-gestational weight gain was the strongest independ-
ent predictor of both birth weight and sum of skinfolds
(Table 2), while the other maternal predictors had more
similar effects on the outcomes. As maternal fasting glu-
cose, HDL-cholesterol, BMI and weight gain were all in-
dependent predictors of birth weight, high levels of
fasting glucose, BMI and weight gain and low levels ofHDL-cholesterol combined (Figure 3, diamond to the
right) gave a heavier neonate than if all factors were ab-
sent (Figure 3, diamond to the left). Likewise, since fast-
ing glucose, 2-hour glucose and weight gain were all
independent predictors of neonatal sum of skinfolds, es-
timations based on a combination of high levels of these
maternal factors (Figure 4, diamond to the right) gave a
higher amount of subcutaneous fat in the neonate than
if all factors were absent (Figure 4, diamond to the left).
Discussion
In this multiethnic, population-based cohort of pregnant
women, we found maternal fasting glucose and HDL-
cholesterol in gestational week 28 to be important pre-
dictors of birth weight, independently of the mother’s
early pregnancy BMI and mid-gestational weight gain.
Maternal fasting and 2-hour glucose in gestational
week 28 were predictors of neonatal sum of skinfolds,
independently of BMI and mid-gestational weight gain.
Figure 4 Predicted sum of skinfolds for the sole and combined
effects of risk factor variables. Based on estimations by the adjusted
multiple regression Model 3. High FG (5.0 mmol/L), 2hG (7.9 mmol/L)
and GWG (0.77 kg/week) were defined as their respective 90 percentile
value. + indicates presence and - absence of the predictor, remaining
variables in the model were set at sample mean. Diamonds are
predicted mean sum of skinfolds and error bars are 95% CI’s. FG = fasting
glucose, 2hG = 2 - hour glucose, GWG=gestational weight gain.
a Predicted sum of skinfolds if maternal BMI was 23 kg/m2, GWG was
0.42 kg/week (according to recommendations from the Institute of
Medicine) [20], FG = 3.9 mmol/L (10 percentile) and 2hG = 4.1 mmol/L
(10 percentile). bPredicted sum of skinfolds if all variables in the multiple
regression model were set at sample mean.
Figure 3 Predicted birth weight for the sole and combined
effects of risk factor variables. Based on estimations by the adjusted
multiple regression Model 3. High FG (5.0 mmol/L), BMI (31.6 kg/m2) and
GWG (0.78 kg/week) were defined as their respective 90 percentile value,
low HDL (1.4 mmol/L) as its 10 percentile value. + indicates presence
and - absence of the predictor, remaining variables in the model were
set at sample mean. Diamonds are predicted mean birth weight and
error bars are 95% CI’s. FG = fasting glucose, HDL =HDL - cholesterol,
GWG= gestational weight gain. a Predicted birth weight if maternal BMI
was 23 kg/m2, GWG was 0.42 kg/week (according to recommendations
from the Institute of Medicine) [20], FG = 3.9 mmol/L (10 percentile) and
HDL = 2.5 mmol/L (90 percentile). b Predicted birth weight if all variables
in the multiple regression model were set at sample mean.
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independent predictor than maternal glucose, lipids
and early pregnancy BMI, for both birth weight and
sum of skinfolds in the offspring. Mid-gestational
weight gain and fasting glucose were the only risk fac-
tor variables that were independent predictors for both
outcomes. Furthermore, the effect size of mother’s
early pregnancy BMI on birth weight was higher in
non-Europeans than in Europeans.
Despite a strong focus on maternal glycemia after the
HAPO study and the proposed new criteria for gesta-
tional diabetes [22], few studies have explored the effects
of glucose and lipid levels on the newborn’s anthropo-
metrics independently of gestational weight gain. Retna-
karan and coworkers [14] also found that weight gain
and BMI were the most important determinants of birth
weight and large for gestational age offspring, independ-
ently of maternal glucose intolerance and lipid levels.
Consistent with our findings, several studies have found
a relationship between maternal fasting glucose and off-
spring’s birth weight [12,23,24], and both maternal fasting
glucose [7] and 2-hour glucose [25] have been associated
with neonatal adiposity. In our study, 2-hour glucose wasindependently associated with offspring’s subcutaneous
fat, but not birth weight.
As found in other studies [26-28], HDL-cholesterol
was inversely related to birth weight in our study. One
study [27] found an inverse association between HDL-
cholesterol and birth weight only in overweight and
obese women and suggested that the effect of HDL-
cholesterol was modified by BMI. However, we found
the same effect of HDL on birth weight in normal
weight women as in overweight women. A study of
underweight and nutrient deficient women [12] did not
find an association between HDL-cholesterol and birth
weight, but this study did not adjust for weight gain and
had a very different study population.
One of the few studies who adjusted for weight gain
in pregnancy [14] did not find any effect of HDL-
cholesterol, LDL-cholesterol or triglycerides on birth
weight, while others have found a positive association
between triglycerides and birth weight [29,30]. It is
possible that the effect of triglycerides was neutralized
by the glucose variables in our multiple regression, as
triglyceride levels will increase when high insulin levels
are present (e.g. in an insulin resistant state). However,
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was relatively weak in our study.
We found no independent effect of BMI on neonatal
sum of skinfolds, while other studies have found an
association between maternal BMI and neonatal adi-
posity [9,31]. In our sample, the association between
BMI and neonatal sum of skinfolds disappeared when
fasting glucose was adjusted for, also when we ex-
cluded women who were diagnosed with gestational
diabetes. BMI reflects maternal body size, such as
muscle mass, skeletal size and body-build in general,
and not merely maternal adiposity. Maternal body
size may affect the size of the offspring due to genetic
traits, but also, a small maternal body size may con-
strain the size of the offspring [32]. Our finding that
BMI had a different effect on birth weight in non-
Europeans than in Europeans, is supported by other
studies who also found interactions between ethnicity
and BMI in relation to prevalence of diabetes [18],
gestational diabetes [33] as well as the risk of off-
spring born large for gestational age in women with ges-
tational diabetes [34]. The fact that this interaction
between BMI and ethnic origin is found in relation to sev-
eral outcomes could mean that non-Europeans have a
lower tolerance of adiposity [18], or that BMI is a poor
measure of adiposity across ethnic groups, or possibly a
combination of both. This is especially concerning consid-
ering the higher prevalence of gestational diabetes and
pre-pregnant BMI found in non-European ethnic groups
in the STORK Groruddalen study [15,21].
Major strengths of the study are the high participation
rate and the inclusion of ethnic minority groups. Our
study sample is considered representative for the major
ethnic groups of pregnant women living in Norway [17].
To our knowledge, this is the first study to show that
the association between maternal glucose and neonatal
skinfolds is independent not only of BMI, but also of
weight gain in pregnancy.
A limitation to our study is that the observational de-
sign cannot prove a causal effect between the maternal
factors and offspring’s anthropometry. Another limita-
tion is the lack of control with the different components
of the weight gain. However, weight gain is easy to
measure, reflects fat gain, and is not likely to cause bias.
Further, the relative weight of the fetus will not be as
pronounced in gestational week 28 as compared to later
in pregnancy. Using weight gain up to measurement of
maternal glucose and lipid levels allowed us to comply
with assumptions of temporality. BMI is generally thought
to reflect adiposity and disease risk differently in Asians
[35]. However, we found the same interaction in all ethnic
minority sub groups, indicating that the interaction we
found was not a result of the problem with using BMI in
Asians. In addition, the interaction between BMI andethnic origin found in our sample did not change the ef-
fect of fasting glucose, HDL-cholesterol or weight gain on
birth weight.
Conclusions
Our results suggest that mid-gestational weight gain
could be more important than hyperglycemia in gesta-
tional week 28 in relation to offspring’s birth weight and
subcutaneous fat. However, maternal prepregnancy BMI,
weight gain, glucose and lipid levels are all factors that
might benefit from lifestyle advice directed at a healthy
diet and increased physical activity, and hence these
should, ideally, be optimized before conception. How-
ever, since health care workers often meet women when
they are already pregnant, promoting an adequate weight
gain during pregnancy may be one of the most import-
ant modifiable factors of birth weight and subcutaneous
fat of the newborn. Future research should explore the
long term effects of maternal glucose and lipids in preg-
nancy, prepregnant obesity and gestational weight gain
on the offspring’s health in childhood and adult life.
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